Targeting ANXA3 in combination with sorafenib for the treatment of hepatocellular carcinoma

被引：0
|
作者：
Tong, Man
Luk, Steve
Che, Noelia
Ding, Jin
Lee, Terence K. W.
Ma, Stephanie
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3146
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The screening of sorafenib analogs for the treatment of hepatocellular carcinoma
    Yu, J.
    Dar, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S77 - S77
  • [42] Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
    Almhanna, Khaldoun
    Philip, Philip A.
    ONCOTARGETS AND THERAPY, 2009, 2 : 261 - 267
  • [43] Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
    Bingru Xie
    David H. Wang
    Stuart Jon Spechler
    Digestive Diseases and Sciences, 2012, 57 : 1122 - 1129
  • [44] Identification of ANXA3 as a biomarker associated with pyroptosis in ischemic stroke
    Linquan Liu
    Yahong Cai
    Changqing Deng
    European Journal of Medical Research, 28
  • [45] Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma
    Samadaei, Mahzeiar
    Senfter, Daniel
    Madlener, Sibylle
    Uranowska, Karolina
    Hafner, Christine
    Trauner, Michael
    Rohr-Udilova, Nataliya
    Pinter, Matthias
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (10) : 1663 - 1673
  • [46] Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
    Hsieh, Chen-Hsi
    Jeng, Kuo-Shyang
    Lin, Ching-Chung
    Chen, Chi-Kuan
    Liu, Chia-Yuan
    Lin, Chin-Ping
    Tai, Hung-Chi
    Wang, Chao-Hsing
    Shueng, Pei-Wei
    Chen, Yu-Jen
    CLINICAL DRUG INVESTIGATION, 2009, 29 (01) : 65 - 71
  • [47] Combination of Sorafenib and Intensity Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
    Chen-Hsi Hsieh
    Kuo-Shyang Jeng
    Ching-Chung Lin
    Chi-Kuan Chen
    Chia-Yuan Liu
    Chin-Ping Lin
    Hung-Chi Tai
    Chao-Hsing Wang
    Pei-Wei Shueng
    Yu-Jen Chen
    Clinical Drug Investigation, 2009, 29 : 65 - 71
  • [48] Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma
    Terashima, Takeshi
    Yamashita, Tatsuya
    Horii, Rika
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    BMC CANCER, 2016, 16
  • [49] Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma
    Takeshi Terashima
    Tatsuya Yamashita
    Rika Horii
    Kuniaki Arai
    Kazunori Kawaguchi
    Kazuya Kitamura
    Taro Yamashita
    Yoshio Sakai
    Eishiro Mizukoshi
    Masao Honda
    Shuichi Kaneko
    BMC Cancer, 16
  • [50] Editorial on combination treatment beyond sorafenib alone for hepatocellular carcinoma with portal vein tumor thrombosis
    Bae, Sun Hyun
    Park, Hee Chul
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S637 - S642
12345